If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations ...

Anti-IL-4Rα monoclonal antibodies are among the best-selling biologics in this field. MG-K10 is an innovative long-acting anti-IL-4Rα humanizedmonoclonal antibody that simultaneously blocks the ...

Toxic smoke and dangerous particulate pollution are spreading far beyond the flames, leaving air quality at unhealthy levels ...

Researchers have identified new lung function and blood test cutoffs to improve timely chronic hypercapnia management in ...

Injurious falls are common among people with chronic obstructive pulmonary disease (COPD) in the two years before de ...

Air pollution choked large parts of Thailand again this morning - as the country's Prime Minister posted pictures of herself ...

Centre, a national research platform led by Nanyang Technological University, Singapore’s (NTU Singapore) Lee Kong Chian School of Medicine (LKCMedicine), will lead a multi-institutional research ...

A recent study conducted by researchers from Seattle-based University of Washington and Durham, N.C.-based Duke University found a strong association between the use of fall-risk increasing drugs and ...

Certain Medicare plans typically cover at least part of the cost of inhalers for COPD. There are also several ways to further save on costs.

Study reveals the Prospector calculator reduces antibiotic prescriptions in COPD exacerbations, improving outcomes and ...

Tezepelumab did not significantly decrease moderate or severe COPD exacerbations compared with placebo, the COURSE trial found.

Individuals in the lowest quintile of birth weight appear to have an increased risk for subsequent chronic obstructive pulmonary disease.